C18:0-d7 GD1b Ceramide (d18:1/18:0-d7)

• UNSPSC Description:

  C18:0-d7 GD1b Ceramide (d18:1/18:0-d7) is deuterium labeled C18:0 GD1b Ceramide (d18:1/18:0)[1].

• Target Antigen:

  Isotope-Labeled Compounds

• Type:

  Isotope-Labeled Compounds

• Related Pathways:

  Others

• Field of Research:

  Others

• Smiles:

  OC[C@@H](O)[C@@H](O)[C@H]1[C@@H](NC(C)=O)[C@@H](O)C[C@@](C(O)=O)(O[C@@H]([C@H]([C@H]2C(NC(C)=O)[C@@H](O)C[C@@](C(O)=O)(O[C@H]3[C@@H](O)[C@H](O[C@H]4[C@@H](O)[C@H]([C@H](OC[C@H](NC(CCCCCCCCCCCCCCC([2H])([2H])C([2H])([2H])C([2H])([2H])[2H])=O)C(O)/C=C/CCCCCCCCCCCCC)O[C@@H]4CO)O)O[C@H](CO)[C@@H]3O[C@@H]5O[C@H](CO)[C@H](O)[C@H](OC6O[C@H](CO)[C@H](O)[C@H](O)[C@H]6O)[C@H]5NC(C)=O)O2)O)CO)O1

• Molecular Weight:

  1845.12

• References & Citations:

  [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported